Reduction of Pectinesterase Activity in a Commercial Enzyme Preparation

Total Page:16

File Type:pdf, Size:1020Kb

Reduction of Pectinesterase Activity in a Commercial Enzyme Preparation Journal of the Science of Food and Agriculture J Sci Food Agric 85:1613–1621 (2005) DOI: 10.1002/jsfa.2154 Reduction of pectinesterase activity in a commercial enzyme preparation by pulsed electric fields: comparison of inactivation kinetic models Joaquın´ Giner, Pascal Grouberman, Vicente Gimeno and Olga Martın´ ∗ Department of Food Technology, University of Lleida, CeRTA-UTPV, ETSEA, Avda Alcalde Rovira Roure 191, 25198-Lleida, Spain Abstract: The inactivation of pectinesterase (PE) in a commercial enzyme preparation (CEP) under high intensity pulsed electric fields (HIPEF) was studied. After desalting and water dilution of the raw CEP, samples were exposed to exponentially decay waveform pulses for up to 463 µs at electric field intensities ranging from 19 to 38 kV cm−1. Pulses were applied in monopolar mode. Experimental data were fitted to a first-order kinetic model as well as to models based on Fermi, Hulsheger¨ or Weibull equations to describe PE inactivation kinetics. Characteristic parameters for each model were calculated. Relationships between some of the parameters and process variables were obtained. The Weibull model yielded the best accuracy factor. The relationship between residual PE and input of electrical energy density was found to be that of exponential decay. 2005 Society of Chemical Industry Keywords: pulsed electric fields; kinetics; pectinesterase; model; inactivation INTRODUCTION It has become customary to use CEPs in fruit and Pectinesterase (PE; EC 3.1.1.11) is a pectic enzyme vegetable juice technology. Depending on the raw which catalyzes the hydrolysis of the methyl ester materials, final products and process requirements, groups in pectin into low methoxylated pectin and processors use specific enzyme formulations for clar- methanol.1 This enzyme is widespread in higher plants ification, maceration or liquefaction and, afterwards, but also can be found as an extracellular enzyme to achieve increased extraction of profitable compo- 18 generated by microorganisms such as yeasts, bacteria nents, clarity, stability, filterability and yield of juice. 19 and fungi. Most plant PEs show maximal activity at To avoid undesirable effects in food products, and neutral or alkaline pH value but fungal PEs usually to eliminate residual PE after achieving the required have optimal activity at acidic pH value.2 amount of change when CEPs are used, heating 12,20 Pectinesterase controls not only relevant physiolog- is commonly used commercially. Unfortunately, heat treatments also cause unavoidable damage, such ical processes in plants in vivo, such as the control of as cooked flavours, colour changes and losses of vita- cell expansion during cell growth and fruit ripening,3–5 mins and nutrients, that lower the quality of the final but also fruit and vegetable processing. Indeed, PE products. is implicated in textural changes during postharvest Among non-thermal treatments that might be used storage, handling and distribution,6,7 and blanching 8 for reducing activity of enzymes while avoiding the of fruits. PE causes undesirable cloud loss of citrus drawbacks of heating, high intensity pulsed electric 9 juices and gelation of concentrates and may adversely fields (HIPEF) are becoming an alternative method affect viscosity and stability of other food products as to heat treatments. Fundamental aspects, equipment 10,11 well. configurations, applications and other general matters Although PE may cause serious technological and of interest related with this technology have been economic troubles for processing of some food reviewed by authors such as Mart´ın et al,21 Barsotti products, the presence of PE activity is indispensable and coworkers,22,23 Barbosa-Canovas´ et al24,25 and in most commercial enzyme preparations (CEP) which Bendicho et al.26 are applied widely nowadays as processing aids in Inactivation of enzymes by HIPEF has been fruit and vegetable juice production.12– 14 Additional reported by various authors. Castro-Castillo27 reduced applications for PE involve peeling of fruits15 and up to 65% alkaline phosphatase activity in milks. analytical determinations as well.16,17 Vega-Mercado and co-workers reported 90% reduc- ∗ Correspondence to: Olga Martın,´ Department of Food Technology, University of Lleida, CeRTA-UTPV, ETSEA, Avda Alcalde Rovira Roure 191, 25198-Lleida, Spain E-mail: [email protected] Contract/grant sponsor: Comision´ Interministerial de Ciencia y Tecnologıa´ (CICYT), Spain; contract/grant number: ALI97-0774; ALI99-1228 (Received 12 September 2003; revised version received 1 November 2004; accepted 2 December 2004) Published online 18 March 2005 2005 Society of Chemical Industry. J Sci Food Agric 0022–5142/2005/$30.00 1613 JGineret al tion of Plasmin28 and reached 60 or 80% inactiva- tion of protease depending on the medium where the enzyme was dispersed.29 Grahl and Markl¨ 30 observed low reduction of alkaline phosphatase and lactoperoxidase activity under HIPEF. Ho et al31 exposed enzymes in aqueous solution to HIPEF and achieved vast reductions in enzyme activity (70–85%) for lipase, glucose oxidase and α-amylase and moderate reduction (30–40%) for peroxidase and polyphenoloxidase. Inactivation of papain (85%) has been reported by Yeom et al.32 Members of our research group have investigated the effect of HIPEF on polyphenoloxidase,33,34 lipase,35 protease36,37 and polygalacturonase;38 the degree of inactivation for these enzymes ranged from 61.2% (lipase) to 98% (polygalacturonase). Min et al39 observed 80% reduc- tion of lipoxygenase. Figure 1. Effect of temperature on electrical conductivity (σ )inthe In contrast, no inactivation, insignificant loss aqueous solution of the desalted commercial enzyme preparation that of activity or even increase of enzyme activity was used to be HIPEF-treated. under HIPEF have also been reported for alka- line phosphatase,30,31,40 lysozyme, pepsin,31 lactate Switzerland) was used as the PE source. The pH 41 30 40 dehydrogenase, lactoperoxidase, , lipoxygenase, and electrical conductivity (σ )fortherawenzyme 40 peroxidase and polyphenoloxidase. preparation at 20 ◦Cwere4.59and13.27 S m−1, Regarding the effects of HIPEF treatments on PE respectively. The solution with pectinesterase activity activity, there are few published accounts and with to be treated by HIPEF (SP) was obtained by desalting 42 conflicting results. Giner et al have studied tomato and diluting the raw enzyme preparation. These PE and achieved a reduction of its activity up to steps were done to lower electrical conductivity of 43,44 93.8% by HIPEF. Yeom et al have also reported the medium to levels that did not cause troubles a significant degree of reduction (83.2%) of orange such as sparking, excessive heating and dielectric PE activity by HIPEF treatments. However, Van Loey breakdown during HIPEF treatments. Thus, 350 g 40 et al obtained no inactivation for PE from orange. of the raw enzyme preparation were poured into Although research on the effects of HIPEF on an Amicon 8400 stirred cell (Millipore Corporation, enzyme activity has increased in the last decade, it Bedford, MA, USA) and ultrafiltrated through a 5000- is patent that available information is still insufficient Da nominal molecular weight filter (Millipore No and, besides, few approaches of modelling inactivation PBCC07610 poly(ether sulfone) membrane, Millipore of enzymes by HIPEF have been published. Only Corporation, Bedford, MA, USA) until 290 g of 39 our research group and Min et al have applied ultrafiltrate had been obtained; the pressure supplier mathematical models to describe the inactivation of was nitrogen gas (Air Liquid SA, Lleida, Spain) enzymes by HIPEF. at 4.5 bar; ultrafiltration was carried out at room This study has the objectives of evaluating the effects temperature. An equal amount of bidistilled water of HIPEF treatments on a fungal PE in a commercial was then added to the concentrated solution and, enzyme preparation using a bench top system as well after mixing, stored at 4 ◦C for 15 h. Finally, and as to test and compare mathematical models which just before HIPEF treatments, the stored solution were useful to describe the effects observed on PE was diluted in a 1:5 mass ratio with bidistilled water activity from the main process variables involved in at 4 ◦C. This diluted solution constituted the SP, such treatments. which had a pH of 4.60. The effect of temperature on the electrical conductivity of SP is shown in Fig 1. MATERIALS AND METHODS A Testo 240 conductivimeter (Testo GmbH & Co, Reagents Lenzkirch, Germany) was used for measurements of Bromocresol green was purchased from Panreac σ , and a Crison micropH 2000 pH-meter (Crison Qu´ımica, SA (Montcada and Reixac, Barcelona, Instruments, Alella, Barcelona, Spain) was used for Spain), esterified pectin from citrus was from Sigma pH measurements. Chemical Co (St Louis, MO, USA) and sodium hydroxide was supplied by Probus, SA (Badalona, PE activity measurement Barcelona, Spain). All chemicals were of analytical The PE activity was determined spectrophotometri- grade. cally following a procedure based on the methodology by Vilarino˜ et al.2 The procedure consisted in follow- PE source and preparation ing the change in absorbance while an enzyme solution A commercial pectolytic enzyme preparation (Pecti- reacted with the substrate, pectin, in the presence of a nex 100 L, Novo Nordisk Ferment Ltd, Neumatt, dye. For this, 10 µl of enzyme solution was added to 1614 J Sci Food Agric 85:1613–1621 (2005) Reduction of pectinesterase activity by pulsed electric fields 1990 µl of pectin–dye solution. Enzyme solution for PE activity assays was obtained by diluting 1 volume of SP (either treated or untreated by HIPEF) into 9 vol- umes bidistilled water. The pectin–dye solution was a mixture of 17.9 ml of pectin and sodium hydroxide stock aqueous solution (both 50 g kg−1)and2mlof bromocresol green stock solution (0.17 g kg−1). This solution was adjusted to pH 4.75 by adding drops of 0.1 M NaOH in order to perform PE assays at the optimum pH of the enzyme.
Recommended publications
  • Genome-Wide Transcriptional Changes and Lipid Profile
    G C A T T A C G G C A T genes Article Genome-Wide Transcriptional Changes and Lipid Profile Modifications Induced by Medicago truncatula N5 Overexpression at an Early Stage of the Symbiotic Interaction with Sinorhizobium meliloti Chiara Santi 1, Barbara Molesini 1, Flavia Guzzo 1, Youry Pii 2 ID , Nicola Vitulo 1 and Tiziana Pandolfini 1,* ID 1 Department of Biotechnology, University of Verona, 37134 Verona, Italy; [email protected] (C.S.); [email protected] (B.M.); fl[email protected] (F.G.); [email protected] (N.V.) 2 Faculty of Science and Technology, Free University of Bozen-Bolzano, 39100 Bolzano BZ, Italy; [email protected] * Correspondence: tiziana.pandolfi[email protected]; Tel.: +39-045-8027918 Received: 30 October 2017; Accepted: 11 December 2017; Published: 19 December 2017 Abstract: Plant lipid-transfer proteins (LTPs) are small basic secreted proteins, which are characterized by lipid-binding capacity and are putatively involved in lipid trafficking. LTPs play a role in several biological processes, including the root nodule symbiosis. In this regard, the Medicago truncatula nodulin 5 (MtN5) LTP has been proved to positively regulate the nodulation capacity, controlling rhizobial infection and nodule primordia invasion. To better define the lipid transfer protein MtN5 function during the symbiosis, we produced MtN5-downregulated and -overexpressing plants, and we analysed the transcriptomic changes occurring in the roots at an early stage of Sinorhizobium meliloti infection. We also carried out the lipid profile analysis of wild type (WT) and MtN5-overexpressing roots after rhizobia infection. The downregulation of MtN5 increased the root hair curling, an early event of rhizobia infection, and concomitantly induced changes in the expression of defence-related genes.
    [Show full text]
  • Download Product Insert (PDF)
    PRODUCT INFORMATION Lysophospholipase D Polyclonal Antibody Item No. 10005375 Overview and Properties Contents: This vial contains 500 µl of peptide affinity-purified antibody. Synonyms: Autotaxin, ENPP2, lysoPLD Immunogen: Peptide from the C-terminal region of rat LysoPLD Species Reactivity: (+) Human, mouse, and rat; other species not tested Form: Liquid Storage: -20°C (as supplied) Stability: ≥1 year Storage Buffer: TBS, pH 7.4, with 50% glycerol, 0.1%l BSA, and 0.02% sodium azide Host: Rabbit Applications: Immunocytochemistry (ICC), Immunohistochemistry (IHC), and Western blot (WB); the recommended starting dilution for ICC is 1:500, 1:80 for IHC, and 1:200 for WB. Other applications were not tested, therefore optimal working concentration/dilution should be determined empirically. Images 1 · · · · · · · 104 kDa · · · · · · · 60 kDa Lane 1: Human cerebella supernatant (40 µg) Immunohistochemistry analysis of formalin-fixed, paraffin-embedded (FFPE) human cerebellum ǎssue aer heat-induced anǎgen retrieval in pH 6.0 citrate buffer. Aer incubaǎon with Lysophospholipase D Polyclonal Anǎbody (Item No. 10005375) at a 1:80 diluǎon, slides were incubated with bioǎnylated secondary anǎbody, followed by alkaline phosphatase-strepavidin and chromogen (DAB). WARNING CAYMAN CHEMICAL THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. 1180 EAST ELLSWORTH RD SAFETY DATA ANN ARBOR, MI 48108 · USA This material should be considered hazardous until further information becomes available. Do not ingest, inhale, get in eyes, on skin, or on clothing. Wash thoroughly after handling. Before use, the user must review the complete Safety Data Sheet, which has been sent via email to your institution. PHONE: [800] 364-9897 WARRANTY AND LIMITATION OF REMEDY [734] 971-3335 Buyer agrees to purchase the material subject to Cayman’s Terms and Conditions.
    [Show full text]
  • Open Matthew R Moreau Ph.D. Dissertation Finalfinal.Pdf
    The Pennsylvania State University The Graduate School Department of Veterinary and Biomedical Sciences Pathobiology Program PATHOGENOMICS AND SOURCE DYNAMICS OF SALMONELLA ENTERICA SEROVAR ENTERITIDIS A Dissertation in Pathobiology by Matthew Raymond Moreau 2015 Matthew R. Moreau Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy May 2015 The Dissertation of Matthew R. Moreau was reviewed and approved* by the following: Subhashinie Kariyawasam Associate Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Bhushan M. Jayarao Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Mary J. Kennett Professor, Veterinary and Biomedical Sciences Vijay Kumar Assistant Professor, Department of Nutritional Sciences Anthony Schmitt Associate Professor, Veterinary and Biomedical Sciences Head of the Pathobiology Graduate Program *Signatures are on file in the Graduate School iii ABSTRACT Salmonella enterica serovar Enteritidis (SE) is one of the most frequent common causes of morbidity and mortality in humans due to consumption of contaminated eggs and egg products. The association between egg contamination and foodborne outbreaks of SE suggests egg derived SE might be more adept to cause human illness than SE from other sources. Therefore, there is a need to understand the molecular mechanisms underlying the ability of egg- derived SE to colonize the chicken intestinal and reproductive tracts and cause disease in the human host. To this end, the present study was carried out in three objectives. The first objective was to sequence two egg-derived SE isolates belonging to the PFGE type JEGX01.0004 to identify the genes that might be involved in SE colonization and/or pathogenesis.
    [Show full text]
  • Diagnostic Value of Serum Enzymes-A Review on Laboratory Investigations
    Review Article ISSN 2250-0480 VOL 5/ ISSUE 4/OCT 2015 DIAGNOSTIC VALUE OF SERUM ENZYMES-A REVIEW ON LABORATORY INVESTIGATIONS. 1VIDYA SAGAR, M.SC., 2DR. VANDANA BERRY, MD AND DR.ROHIT J. CHAUDHARY, MD 1Vice Principal, Institute of Allied Health Sciences, Christian Medical College, Ludhiana 2Professor & Ex-Head of Microbiology Christian Medical College, Ludhiana 3Assistant Professor Department of Biochemistry Christian Medical College, Ludhiana ABSTRACT Enzymes are produced intracellularly, and released into the plasma and body fluids, where their activities can be measured by their abilities to accelerate the particular chemical reactions they catalyze. But different serum enzymes are raised when different tissues are damaged. So serum enzyme determination can be used both to detect cellular damage and to suggest its location in situ. Some of the biochemical markers such as alanine aminotransferase, aspartate aminotransferase, alkaline phasphatase, gamma glutamyl transferase, nucleotidase, ceruloplasmin, alpha fetoprotein, amylase, lipase, creatine phosphokinase and lactate dehydrogenase are mentioned to evaluate diseases of liver, pancreas, skeletal muscle, bone, etc. Such enzyme test may assist the physician in diagnosis and treatment. KEYWORDS: Liver Function tests, Serum Amylase, Lipase, CPK and LDH. INTRODUCTION mitochondrial AST is seen in extensive tissue necrosis during myocardial infarction and also in chronic Liver diseases like liver tissue degeneration DIAGNOSTIC SERUM ENZYME and necrosis². But lesser amounts are found in Enzymes are very helpful in the diagnosis of brain, pancreas and lung. Although GPT is plentiful cardiac, hepatic, pancreatic, muscular, skeltal and in the liver and occurs only in the small amount in malignant disorders. Serum for all enzyme tests the other tissues.
    [Show full text]
  • GANNABAN-THESIS-2019.Pdf
    Identification of novel sources of variation for the improvement of cold germination ability and early seedling vigor in upland cotton (Gossypium hirsutum L.) by Ritchel Bueno Gannaban, B.S. A Thesis In Plant and Soil Science Submitted to the Graduate Faculty of Texas Tech University in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCES Approved Dr. Rosalyn B. Angeles-Shim Chair of Committee Dr. Benildo G. de los Reyes Dr. Brendan R. Kelly Dr. Endang Septiningsih Mark Sheridan Dean of the Graduate School August, 2019 Copyright 2019, Ritchel Bueno Gannaban Texas Tech University, Ritchel Bueno Gannaban, August 2019 ACKNOWLEDGMENTS It is my pleasure to acknowledge everyone whose efforts and contributions led me to the completion of this research study. Without the support and encouragement, I would not have been able to complete this very important chapter of my life’s journey. I would like to thank my thesis advisor, Dr. Rosalyn B. Angeles-Shim of the Department of Plant and Soil Science at Texas Tech University. Dr. Shim provided the opportunity for me to pursue my graduate studies. With her guidance, I managed to survive the grueling life of a graduate student. Dr. Shim’s office was always open whenever I had a question about my research or writing. She consistently allowed this paper to be my own work, but steered me in the right direction whenever she thought I needed it. Not only she is a very considerate adviser but also a confidant who never fails to see the potential in every person. It is truly an honor to work under a great mentor.
    [Show full text]
  • What Is Alkaline Phosphatase? What Are the Symptoms of Low ALP?
    What is the treatment for HPP? In 2015, asfotase alfa (Strensiq™) was approved for use in the US, the European Union, and Canada for pediatric-onset HPP, and in Japan for HPP with onset at any age. The medication is an injection given multiple times per week underneath the skin (subcutaneous). It is a recombinant (factory-made) form of ALP that has a bone-targeting component. When patients take asfotase alfa, ALP levels measured in the blood are quite high (often in the multiple thousands). Therefore, measuring ALP levels is typically not helpful once a patient is on therapy. What is Alkaline Phosphatase? What are the symptoms of low ALP? For more information, please contact Patients with hypophosphatasia (HPP) have Low ALP can lead to multiple symptoms of HPP, the Soft Bones Foundation. a low blood alkaline phosphatase (ALP) level. including poor bone mineralization and rickets as well (866) 827-9937 – Toll Free as early tooth loss (prior to age 5 years). It is also (973) 453-3093 – Direct Line thought that PPi may build up in muscle tissue 121 Hawkins Place, #267 ALP is an enzyme (a protein that breaks down and may be responsible for the pain and muscle Boonton, New Jersey 07005 chemicals). Most health providers are aware that weakness that some patients with HPP experience. www.SoftBones.org high ALP levels may indicate medical problems, such as liver disease or other bone diseases besides HPP, but many providers may not recognize that low ALP levels can indicate HPP. Low ALP is important What questions should patients ask Written by because the inability to break down chemicals can their doctors about ALP? Jill Simmons, MD lead to elevated levels of these chemicals, which Associate Professor of Pediatrics, Ian Burr Division can cause multiple problems.
    [Show full text]
  • Effect of Alkaline Phosphatase on the Function of Purified Reverse Transcriptase in Reconstructed Reverse Transcription (116 Pp) Director: Kenneth F
    University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 1984 Effect of alkaline phosphatase on the function of purified er verse transcriptase in reconstructed reverse transcription Michael J. Wolkowicz The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Wolkowicz, Michael J., "Effect of alkaline phosphatase on the function of purified er verse transcriptase in reconstructed reverse transcription" (1984). Graduate Student Theses, Dissertations, & Professional Papers. 7480. https://scholarworks.umt.edu/etd/7480 This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. COPYRIGHT ACT OF 1976 This is an unpublished manuscript in which copyright sub­ s i s t s . Any further reprinting of its contents must be approved BY THE a u t h o r . Mansfield Library University of Montana Date ; 1 G 8 5 EFFECT OF ALKALINE PHOSPHATASE ON THE FUNCTION OF PURIFIED REVERSE TRANSCRIPTASE IN RECONSTRUCTED REVERSE TRANSCRIPTION By Michael J. Wolkowicz B. A. American International College, 1976 B. S. University of Montana, 1980 Presented in partial fulfillment of the requirements for the degree of Masters of Science UNIVERSITY OF MONTANA 1984 Approved by: iP- airman. Board of Examiners D^n, Graduater'school Date UMI Number: EP38281 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted.
    [Show full text]
  • The Characterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry
    Louisiana State University LSU Digital Commons LSU Historical Dissertations and Theses Graduate School 1999 The hC aracterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry. Lenore Marie Polo Louisiana State University and Agricultural & Mechanical College Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses Recommended Citation Polo, Lenore Marie, "The hC aracterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry." (1999). LSU Historical Dissertations and Theses. 6923. https://digitalcommons.lsu.edu/gradschool_disstheses/6923 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter free, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand corner and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Enzymes for Cell Dissociation and Lysis
    Issue 2, 2006 FOR LIFE SCIENCE RESEARCH DETACHMENT OF CULTURED CELLS LYSIS AND PROTOPLAST PREPARATION OF: Yeast Bacteria Plant Cells PERMEABILIZATION OF MAMMALIAN CELLS MITOCHONDRIA ISOLATION Schematic representation of plant and bacterial cell wall structure. Foreground: Plant cell wall structure Background: Bacterial cell wall structure Enzymes for Cell Dissociation and Lysis sigma-aldrich.com The Sigma Aldrich Web site offers several new tools to help fuel your metabolomics and nutrition research FOR LIFE SCIENCE RESEARCH Issue 2, 2006 Sigma-Aldrich Corporation 3050 Spruce Avenue St. Louis, MO 63103 Table of Contents The new Metabolomics Resource Center at: Enzymes for Cell Dissociation and Lysis sigma-aldrich.com/metpath Sigma-Aldrich is proud of our continuing alliance with the Enzymes for Cell Detachment International Union of Biochemistry and Molecular Biology. Together and Tissue Dissociation Collagenase ..........................................................1 we produce, animate and publish the Nicholson Metabolic Pathway Hyaluronidase ...................................................... 7 Charts, created and continually updated by Dr. Donald Nicholson. DNase ................................................................. 8 These classic resources can be downloaded from the Sigma-Aldrich Elastase ............................................................... 9 Web site as PDF or GIF files at no charge. This site also features our Papain ................................................................10 Protease Type XIV
    [Show full text]
  • Regulation of Fructose-6-Phosphate 2-Kinase By
    Proc. Natt Acad. Sci. USA Vol. 79, pp. 325-329, January 1982 Biochemistry Regulation of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation: Possible mechanism for coordinated control of glycolysis and glycogenolysis (phosphofructokinase) EISUKE FURUYA*, MOTOKO YOKOYAMA, AND KOSAKU UYEDAt Pre-Clinical Science Unit of the Veterans Administration Medical Center, 4500 South Lancaster Road, Dallas, Texas 75216; and Biochemistry Department of the University ofTexas Health Science Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235 Communicated by Jesse C. Rabinowitz, September 28, 1981 ABSTRACT The kinetic properties and the control mecha- Fructose 6-phosphate + ATP nism of fructose-6-phosphate 2-kinase (ATP: D-fructose-6-phos- -3 Fructose + ADP. [1] phate 2-phosphotransferase) were investigated. The molecular 2,6-bisphosphate weight of the enzyme is -100,000 as determined by gel filtration. The plot of initial velocity versus ATP concentration is hyperbolic We have shown that the administration of extremely low con- with a K. of 1.2 mM. However, the plot of enzyme activity as a centrations of glucagon (0.1 fM) or high concentrations of epi- function of fructose 6-phosphate is sigmoidal. The apparent K0.5 nephrine (10 ,uM) to hepatocytes results in inactivation offruc- for fructose 6-phosphate is 20 ,IM. Fructose-6-phosphate 2-kinase tose-6-phosphate 2-kinase and concomitant decrease in the is inactivated by -the catalytic subunit of cyclic AMP-dependent fructose 2,6-bisphosphate level (12). These results, as well as protein kinase, and the inactivation is closely correlated with phos- more recent data using Ca2+ and the Ca2+ ionophore A23187 phorylation.
    [Show full text]
  • Simple, Sensitive Detection of Protein Phosphodiesterase Activity Measure Real-Time Signal Differences in the Picomole Range with the Phosphate Sensor Method
    APPLICATION NOTE Phosphodiesterase Activity: A Phophate Sensor Application Simple, Sensitive Detection of Protein Phosphodiesterase Activity Measure real-time signal differences in the picomole range with the Phosphate Sensor method Described in this application is a method utilizing the Life Technologies Phosphate Sensor, a simple tool to interrogate the activity of phosphate-releasing enzymes. The assays described detect the increase of fluorescence intensity when free inorganic phosphate binds to a bacterially derived phosphate-binding protein modified with a fluorophore.To evaluate the Phosphate Sensor methods, we compared detection by coupling to an alkaline phosphatase against a commonly used coupled luciferase assay, examined responses for human phosphodiesterase A (PTE5A) in a titration, in real-time kinetic mode, and with a sildenafil citrate inhibitor. Phosphate Sensor is orders of magnitude more sensitive than the coupled luciferase method, faster and simpler to use than other competitor methods, and uniquely qualified for determining enzymatic rates. Second messenger systems that involve an increase or decrease of cyclic nucleotides (cAMP or cGMP) mediate intracellular signal trans- duction. Nucleotide degradation regulates this process and is mediated through the action of phosphodiesterase (PDE) enzymes, which also play an integral role in a number of disorders including erectile dysfunction [1], asthma [2], and chronic obstructive pulmonary disease [2], as well as schizophrenia, bipolar disorder, and major depression [3]. As research identifies additional potential drug targets, methodologies for measur- ing activity become vital. Figure 1. Phosphate Sensor assay principle. The protein ribbon diagram illustrates the modified We describe here the use and optimization of a simple, flexible reagent phosphate-binding protein with the MDCC fluoro- for measurement of phosphodiesterase activity through coupling it with phore (shown in blue).
    [Show full text]
  • Lab Test Interpretation Table*
    Lab Test Interpretation Table* Normal Range** Interpretation Tips Hematology White Blood Cell Count (WBC) WBCs are measured as part of a complete blood & Differential count and differential (CBC & diff). They protect the body from infection. Leukocytes/WBC 4 – 10 x 109 /L Increased Counts Neutrophils - Leukocytosis and neutrophilia can be caused by Absolute Neutrophil Count (ANC) = - infection, myeloproliferative disorders, 2 – 7.5 x 109/L inflammation, and medications. - Calculated ANC = WBC x (segs+bands) / 100 o In cancer patients, supportive - Band neutrophils: < 0.7 x 109/L medications such as corticosteroids and 9 colony stimulating factors can cause Basophils < 0.2 x 10 /L elevated counts. Treatment is not Eosinophils < 0.7 x 109/L required unless they are associated with 9 bone pain, which may improve with Lymphocytes = 1 – 4 x 10 /L analgesic therapy. 9 Monocytes = 0.1 – 0.8 x 10 /L o When leukocytosis is accompanied by increased immature neutrophils (band neutrophils) and fever, infection is a likely cause. Band neutrophils often increase in number to fight infections (also called “a shift to the left”). - Elevated lymphocyte counts are associated with increased risk of cytokine-release syndrome (see BC Cancer Protocol LYCHOPR) or tumour lysis syndrome (see BC Cancer Protocol ULYVENETO) and prophylaxis may be indicated. Consult respective protocol and/or tumor group chair for management recommendations. Decreased Counts - Leukocytopenia and neutropenia can result from nutritional deficiency, autoimmune disease, bone marrow infiltration (i.e., leukemia or myelodysplastic syndrome), radiation, and myelosuppression due to medications (including many cancer drugs). o Many treatment protocols require dose adjustments or the addition of colony stimulating factors (e.g., filgrastim) if ANC drops below 1.5 x 109/L.
    [Show full text]